Fucoidan as a Potential Therapeutic for Major Blinding Diseases—A Hypothesis
Department of Ophthalmology, University Medical Center, University of Kiel, 24105 Kiel, Germany
Academic Editor: Paola Laurienzo
Mar. Drugs 2016, 14(2), 31; https://doi.org/10.3390/md14020031
Received: 30 November 2015
/
Revised: 12 January 2016
/
Accepted: 22 January 2016
/
Published: 3 February 2016
(This article belongs to the Collection Marine Polysaccharides)
Fucoidan is a heterogeneous group of sulfated polysaccharide with a high content of l-fucose, which can be extracted from brown algae and marine invertebrates. It has many beneficial biological activities that make fucoidan an interesting candidate for therapeutic application in a variety of diseases. Age-related macular degeneration and diabetic retinopathy are major causes for vision loss and blindness in the industrialized countries and increasingly in the developing world. Some of the characteristics found in certain fucoidans, such as its anti-oxidant activity, complement inhibition or interaction with the Vascular Endothelial Growth factor, which would be of high interest for a potential application of fucoidan in age-related macular degeneration or diabetic retinopathy. However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological activities of fucoidan that could be of interest regarding these diseases will be discussed.
View Full-Text
Keywords:
fucoidan; age-related macular degeneration; diabetic retinopathy; oxidative stress; VEGF; complement
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Klettner, A. Fucoidan as a Potential Therapeutic for Major Blinding Diseases—A Hypothesis. Mar. Drugs 2016, 14, 31. https://doi.org/10.3390/md14020031
AMA Style
Klettner A. Fucoidan as a Potential Therapeutic for Major Blinding Diseases—A Hypothesis. Marine Drugs. 2016; 14(2):31. https://doi.org/10.3390/md14020031
Chicago/Turabian StyleKlettner, Alexa. 2016. "Fucoidan as a Potential Therapeutic for Major Blinding Diseases—A Hypothesis" Marine Drugs 14, no. 2: 31. https://doi.org/10.3390/md14020031
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
